We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00954889
Recruitment Status : Unknown
Verified October 2011 by Samsung Medical Center.
Recruitment status was:  Active, not recruiting
First Posted : August 7, 2009
Last Update Posted : November 1, 2011
Sponsor:
Information provided by (Responsible Party):
Samsung Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : November 2011
  Study Completion Date : No date given